YI JianshengSenior Partner
Mr. YI began to practice law in 2007, mainly specializing in fields of corporate restructuring and refinancing, acquisition and restructuring of listed companies, industry integration and M&A.
Office：Beijing
Tel：86-10-66413377
E-mail：yijiansheng@jiayuan-law.com
Language：Chinese, English
Representative Deals
- Corporate Restructuring and Listing in China or Overseas
China Resources Pharmaceutical Group’s H share IPO
CMS’s H share IPO
CRCC High-Tech Equipment’s H share IPO
Wenzhou Kangning Hospital’s H share IPO
GF Securities’ H share IPO
China Energy Engineering’s H shares IPO
BAIC Motor’s H share IPO
IM Resources’ H share IPO
Jiangxi Gas’ asset restructuring and A share IPO
Harbin Bank’s H share IPO
China Coal Energy Company Limited’s A share IPO
MCC’s A and H share IPO
Shaanxi Coal Industry’s A share IPO
Inner Mongolia Yitai Group’s H share IPO
Shuicheng Kuangye Group’s asset restructuring and A share IPO
China Minmetals’ and China Railway Materials’ restructuring and A share IPO
Beijing Hanjian Heshan Pipeline Industry’s A share IPO
CMEC’s restructuring and H share IPO
Chenming Group’s H share SEO - Perennial Legal Advisor
Shaanxi Coal Industry, Yangling Besun Group, China Coal Energy, MCC, China Energy Engineering, CRCC High-Tech Equipment, BAIC Motor, GF Securities, China National Biotec Group, Beijing Tiantan Biological Products, Beijing Hanjian Heshan Pipeline , Beijing Baofeng Technology and other listed and non-listed companies. - M&A
Sinohydro Real Estate’s acquisition of Wuhan Langold Real Estate by tender offer and part of real estate projects
Shaanxi Coal Industry’s acquisition of Port Authority in Xiangyang
China Coal Energy’s partial acquisition of coal companies in Shanxi
Guangdong WENS Group’s merger by absorption of Dahuanong Biotechnology
SDIC’s transfer of shares
Jiesai’s purchasing assets by share issuance
Beijing Tiantan Biological Products’s major assets restructuring - Issuing Securities in China and Overseas
China Coal Energy, Shaanxi Coal Industry, China National Biotec Group and MCC’s issuance of debt financing instruments and corporate bonds in the interbank market; Haitong International, CREC, China Minmetals and MCC or its subsidiaries’ issuance of offshore bonds; Zhejiang Expressway’s H shares of convertible bonds.
Education
- 2005, Bachelor’s Degree in Management Science, Dalian Maritime University
- 2007, LLM, Renmin University of China
Bar Admission
- 2010, PRC
